“Therapeutic Effects of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors in Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”. Althea Medical Journal, vol. 12, no. 3, Sept. 2025, pp. 161-7, https://doi.org/10.15850/amj.v12n3.4209.